1044 — Hengan International Share News
0.000.00%
Last trade - 00:00- HK$22.76bn
- HK$22.11bn
- CNY23.07bn
Focus: Chinese baby product firms seek to age up, sell more abroad as population falls
Brief: Hengan International Reports FY Profit Attributable RMB1.93 Billion
Brief: Hengan International Updates On Super Short-Term Commercial Papers
Brief: Starpharma Says It Signed Sales & Distribution Agreement For Viraleze In HK, Macau
Australia's Starpharma rises on distribution deal for nasal spray in HK, Macau
Brief: Hengan International Says HY Profit Attributable Rmb1.28 Bln
China's napkin maker Hengan near 13-year low on profit drop, lower dividend
Brief: Hengan International Posts FY Profit Attributable Of RMB 3.27 Bln
Brief: Hengan International Posts HY Profit Attributable Rmb1.86 Billion
Hong Kong-listed Hengan sinks to 12-year low on weak H1 results
Chinese tissue maker Hengan sinks to near 12-year low; Daiwa downgrades
Brief: Hengan International Says Hui Lin Chit Resigned As CEO
Hong Kong shares hit 10-week closing low on policy tightening concerns (updated)
Hong Kong, China shares slump as policy tightening concerns persist
Brief: Hengan International Posts FY Profit Attributable RMB4.59 Bln Vs RMB3.91 Bln
Alibaba Health leads gains among newcomers to Hong Kong's benchmark indexes
Brief: Alibaba Health Information, Haidilao to join benchmark Hang Seng Index
Brief: Hengan International Group Received Approval Document By CSRC To Issue Domestic Bonds
Brief: Hengan International Group Says China Securities Regulatory Commission Approved Issue Of Domestic Bonds